Findings of Research Misconduct, 67870 [E6-19889]

Download as PDF cprice-sewell on PROD1PC66 with NOTICES 67870 Federal Register / Vol. 71, No. 226 / Friday, November 24, 2006 / Notices case studies to two children’s disorders that appear to have environmental etiologies but are less well understood: disorders of lipid and carbohydrate metabolism and attention deficit/ hyperactivity disorder (ADHD). A discussion will follow each case study presentation to consider the opportunities, the barriers and the design challenges that confront future clinical, toxicological, epidemiological, exposure monitoring, and basic research in children’s environmental health. Specific topics include: • Past approaches to research translation to see what worked and what failed to work. • The critical mass of researchers and mix of disciplines needed to most efficiently advance research in children’s environmental health. • Biomarkers of exposure, susceptibility, or subclinical dysfunction. • The use of ‘‘omics’’ technologies that might be incorporated into future toxicological, epidemiological and/or biomonitoring studies to enhance their sensitivity and efficiency. • Is there a point at which the use of new scientific tools might slow the pace of progress? • New approaches to accelerating the translation of science to treatment, prevention, and the remediation of environmental risks to children’s health. • Potential study populations at uniquely high risk of disease. • Data resources—records, disease registries, well-characterized cohort populations, tissue banks, or stored DNA—in the U.S. or abroad that might facilitate future studies. • New partnerships in research. DATES: The workshop will be held on January 22–23, 2007, at the NIEHS in Research Triangle Park, North Carolina. Individuals who plan to attend are encouraged to register online at https:// www.apps.niehs.nih.gov/conferences/ od/cehr/ as soon as possible because seating is limited. Please note that a photo ID is required to access the NIEHS campus. Persons needing special assistance, such as sign language interpretation or other reasonable accommodation in order to attend, should contact 919–541–2475 voice, 919–541–4644 TTY (text telephone), through the Federal TTY Relay System at 800–877–8339, or by e-mail to niehsoeeo@niehs.nih.gov. Requests should be made at least 7 days in advance of the event. ADDRESSES: The workshop will be held in the Rodbell Auditorium, Rall Building at the NIEHS, 111 T.W. Alexander Drive, Research Triangle Park, NC, 27709. VerDate Aug<31>2005 13:24 Nov 22, 2006 Jkt 211001 Any correspondence should be submitted to Dr. Kristina Thayer (NIEHS, P.O. Box 12233, MD B2–01, Research Triangle Park, NC, 27709; telephone: 919–541– 5021 or e-mail: thayer@niehs.nih.gov). FOR FURTHER INFORMATION CONTACT: Dated: November 9, 2006. Samuel H. Wilson, Deputy Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E6–19807 Filed 11–22–06; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case: James C. Lin, Ph.D., University of Illinois at Chicago: Based on the findings from an inquiry by the University of Illinois at Chicago (UIC) and on additional analysis conducted by ORI during its oversight review, the U.S. Public Health Service (PHS) found that James C. Lin, Ph.D., Professor, Department of Electrical and Computer Engineering, Physiology, and Biophysics, UIC, engaged in research misconduct concerning National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), grant application 1 R01 NS47238–01, ‘‘Blood-Brain Barrier Interactions of Cellular-Phone Radi.’’ Specifically, PHS found that Dr. Lin committed research misconduct relative to the legend and related text for Figure 2 (data from a colleague on other experiments) for his NIH application 1 R01 NS47238–01, by falsely claiming the figure represented preliminary results of his independent experiments that differed from the source of the figure and the prior research in the field, in which he purported to have selectively exposed the rat’s head to microwave irradiation, to have utilized higher peak exposure, of shorter duration and of different radio frequencies, and which reported injury of more acute nature to the blood barrier. Dr. Lin denies all allegations of research misconduct and contends that some of his original data is missing as a result of the involuntary relocation of PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 his laboratory. Dr. Lin makes no admission of guilt in connection with the charges or PHS’ findings of research misconduct herein. Both Dr. Lin and PHS are desirous of concluding this matter without further expense of time and other resources. Dr. Lin has entered into a Voluntary Exclusion Agreement in which he has voluntarily agreed, for a period of three (3) years, beginning on October 24, 2006: (1) That any institution which submits an application for PHS support for a research project on which Dr. Lin’s participation is proposed or which uses him in any capacity on PHS supported research, or that submits a report of PHS-funded research in which Dr. Lin is involved, must concurrently submit a plan for supervision of Dr. Lin’s duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of his research contribution. Dr. Lin agrees to ensure that a copy of the supervisory plan also is submitted to ORI by the institution. He also agrees that he will not participate in any PHS-supported research until such a supervision plan is submitted to ORI; (2) that any institution employing Dr. Lin submit in conjunction with each application for PHS funds or reports, manuscripts, or abstracts of PHS-funded research in which Dr. Lin is involved a certification that the data provided by Dr. Lin are based on actual experiments or are otherwise legitimately derived and that the data, procedures, and methodology are accurately reported in the application or report. Dr. Lin must ensure that the institution also sends a copy of the certification to ORI; and (3) to exclude himself from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E6–19889 Filed 11–22–06; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Misconduct in Science AGENCY: E:\FR\FM\24NON1.SGM Office of the Secretary, HHS. 24NON1

Agencies

[Federal Register Volume 71, Number 226 (Friday, November 24, 2006)]
[Notices]
[Page 67870]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-19889]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) and the Assistant Secretary for Health have taken final action in 
the following case:
    James C. Lin, Ph.D., University of Illinois at Chicago: Based on 
the findings from an inquiry by the University of Illinois at Chicago 
(UIC) and on additional analysis conducted by ORI during its oversight 
review, the U.S. Public Health Service (PHS) found that James C. Lin, 
Ph.D., Professor, Department of Electrical and Computer Engineering, 
Physiology, and Biophysics, UIC, engaged in research misconduct 
concerning National Institute of Neurological Disorders and Stroke 
(NINDS), National Institutes of Health (NIH), grant application 1 R01 
NS47238-01, ``Blood-Brain Barrier Interactions of Cellular-Phone 
Radi.''
    Specifically, PHS found that Dr. Lin committed research misconduct 
relative to the legend and related text for Figure 2 (data from a 
colleague on other experiments) for his NIH application 1 R01 NS47238-
01, by falsely claiming the figure represented preliminary results of 
his independent experiments that differed from the source of the figure 
and the prior research in the field, in which he purported to have 
selectively exposed the rat's head to microwave irradiation, to have 
utilized higher peak exposure, of shorter duration and of different 
radio frequencies, and which reported injury of more acute nature to 
the blood barrier.
    Dr. Lin denies all allegations of research misconduct and contends 
that some of his original data is missing as a result of the 
involuntary relocation of his laboratory. Dr. Lin makes no admission of 
guilt in connection with the charges or PHS' findings of research 
misconduct herein. Both Dr. Lin and PHS are desirous of concluding this 
matter without further expense of time and other resources.
    Dr. Lin has entered into a Voluntary Exclusion Agreement in which 
he has voluntarily agreed, for a period of three (3) years, beginning 
on October 24, 2006:
    (1) That any institution which submits an application for PHS 
support for a research project on which Dr. Lin's participation is 
proposed or which uses him in any capacity on PHS supported research, 
or that submits a report of PHS-funded research in which Dr. Lin is 
involved, must concurrently submit a plan for supervision of Dr. Lin's 
duties to the funding agency for approval. The supervisory plan must be 
designed to ensure the scientific integrity of his research 
contribution. Dr. Lin agrees to ensure that a copy of the supervisory 
plan also is submitted to ORI by the institution. He also agrees that 
he will not participate in any PHS-supported research until such a 
supervision plan is submitted to ORI;
    (2) that any institution employing Dr. Lin submit in conjunction 
with each application for PHS funds or reports, manuscripts, or 
abstracts of PHS-funded research in which Dr. Lin is involved a 
certification that the data provided by Dr. Lin are based on actual 
experiments or are otherwise legitimately derived and that the data, 
procedures, and methodology are accurately reported in the application 
or report. Dr. Lin must ensure that the institution also sends a copy 
of the certification to ORI; and
    (3) to exclude himself from serving in any advisory capacity to 
PHS, including but not limited to service on any PHS advisory 
committee, board, and/or peer review committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
 [FR Doc. E6-19889 Filed 11-22-06; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.